Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IMMUCELL CORP /DE/ Director's Dealing 2019

Dec 12, 2019

34519_dirs_2019-12-12_02407f72-d87e-46f7-80a5-cc6a23cf80fe.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IMMUCELL CORP /DE/ (ICCC)
CIK: 0000811641
Period of Report: 2019-12-11

Reporting Person: Williams Elizabeth Luttrell (N/A)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-12-11 Incentive Stock Options (Right to buy) $5.1750 A 10000.0000 Acquired 2029-12-11 Common Stock (10000.0000) Direct